Back
Arbutus Biopharma Stock Price Chart

Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
41
ABUS
Arbutus Biopharma
Last Price:
$3.19
Seasonality Move:
19.59%
7 Day Trial
ALL ACCESS PASS
$
7

Former Zillow execs target $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABUS is experiencing buying pressure, which is a positive indicator for future bullish movement.
Arbutus Biopharma Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.4 | Sell |
20-day SMA: | 3.32 | Buy |
50-day SMA: | 3.3 | Buy |
200-day SMA: | 3.58 | Sell |
8-day EMA: | 3.35 | Buy |
20-day EMA: | 3.34 | Buy |
50-day EMA: | 3.33 | Buy |
200-day EMA: | 3.37 | Sell |
Arbutus Biopharma Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.02 | Buy |
Relative Strength Index (14 RSI): | 51.02 | Buy |
Chaikin Money Flow: | 556209 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.1 - 3.44) | Buy |
Bollinger Bands (100): | (3.18 - 3.44) | Buy |
Arbutus Biopharma Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Arbutus Biopharma Stock
Is Arbutus Biopharma Stock a Buy?
-
Arbutus Biopharma share price is 3.35 while ABUS 8-day simple moving average is 3.40, which is a Sell signal.
-
The stock price of ABUS is 3.35 while Arbutus Biopharma 20-day SMA is 3.32, which makes it a Buy.
-
Arbutus Biopharma 50-day simple moving average is 3.30 while ABUS share price is 3.35, making it a Buy technically.
-
ABUS stock price is 3.35 and Arbutus Biopharma 200-day simple moving average is 3.58, creating a Sell signal.
ABUS Technical Analysis vs Fundamental Analysis
Sell
41
Arbutus Biopharma (ABUS)
is a Sell
Is Arbutus Biopharma a Buy or a Sell?
-
Arbutus Biopharma stock is rated a SellThe current Arbutus Biopharma [ABUS] share price is $3.35. The Score for ABUS is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
Arbutus Biopharma Stock Info
Market Cap:
641.5M
Price in USD:
3.35
Share Volume:
834.3K
Arbutus Biopharma 52-Week Range
52-Week High:
4.73
52-Week Low:
2.71
Sell
41
Arbutus Biopharma (ABUS)
is a Sell
Arbutus Biopharma Share Price Forecast
-
What is the Arbutus Biopharma stock price today?The Arbutus Biopharma stock price is 3.35 USD today.
-
Will ABUS stock go up or go down?Arbutus Biopharma> share price is forecast to RISE/FALL based on technical indicators
-
Is Arbutus Biopharma overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Arbutus Biopharma is overvalued.
Is Arbutus Biopharma Stock a Buy?
-
Arbutus Biopharma share price is 3.35 while ABUS 8-day exponential moving average is 3.35, which is a Buy signal.
-
The stock price of ABUS is 3.35 while Arbutus Biopharma 20-day EMA is 3.34, which makes it a Buy.
-
Arbutus Biopharma 50-day exponential moving average is 3.33 while ABUS share price is 3.35, making it a Buy technically.
-
ABUS stock price is 3.35 and Arbutus Biopharma 200-day simple moving average is 3.37, creating a Sell signal.
Fundamental Analysis of Arbutus Biopharma
Is Arbutus Biopharma a good investment?
-
Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.16 per share, and an increase next year of $0.13 per share.
Technical Analysis of Arbutus Biopharma
Should I short Arbutus Biopharma stock?
-
ABUS Moving Average Covergence Divergence (MACD) indicator is 0.02, suggesting Arbutus Biopharma is a Buy
-
Arbutus Biopharma Relative Strength Index (RSI) is 51.02, which suggest Arbutus Biopharma is overbought
-
The Bollinger Bands (25) for Arbutus Biopharma is (3.1 - 3.44), which suggest Arbutus Biopharma is a Buy
-
The Bollinger Bands (100) for Arbutus Biopharma is (3.18 - 3.44), which suggest Arbutus Biopharma is a Buy
* Arbutus Biopharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.